Abbott Laboratories (ABT)

CIK 0000001800 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-16) · 99.1
Q1-2026 8-K (2026-04-16) · 99.1
Latest FY-2025 8-K (2026-01-22) · 99.1
Q3-2025 8-K (2025-10-15) · 99.1
Q2-2025 8-K (2025-07-17) · 99.1
Q1-2025 8-K (2025-04-16) · 99.1
FY-2024 8-K (2025-01-22) · 99.1
Q3-2024 8-K (2024-10-16) · 99.1
Q2-2024 8-K (2024-07-18) · 99.1
Q1-2024 8-K (2024-04-17) · 99.1
FY-2023 8-K (2024-01-24) · 99.1
Q3-2023 8-K (2023-10-18) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Statement of Earnings
Consolidated Statement of Comprehensive Income
Consolidated Statement of Comprehensive Income (P)
Consolidated Balance Sheet
Consolidated Balance Sheet (P)
Consolidated Statement of Shareholders' Investment
Consolidated Statement of Shareholders' Investment (P)
Consolidated Statement of Cash Flows
Notes
Accumulated Other Comprehensive Income (loss)
—
Basis of Presentation
—
Business Acquisitions
Changes In Accumulated Other Comprehensive Income (loss)
—
Cybersecurity Risk Management and Strategy Disclosure
—
Debt and Lines of Credit
Financial Instruments, Derivatives and Fair Value Measures
Financial Instruments, Derivatives, and Fair Value Measures
—
Goodwill and Intangible Assets
Incentive Stock Program
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
—
Litigation and Environmental Matters
New Accounting Standards
Pay Vs Performance Disclosure
Post-employment Benefits
Restructuring Plans
Revenue
Schedule Ii Valuation and Qualifying Accounts
—
Segment and Geographic Area Information
—
Segment Information
—
Summary of Significant Accounting Policies
—
Supplemental Financial Information
Taxes On Earnings